Works matching IS 15257304 AND DT 2015 AND VI 16 AND IP 2

Results: 16

Stereotactic radiotherapy in the treatment of primary bronchial carcinoid tumor.

Published in:

2015

By:

Colaco, Rovel J;
Decker, Roy H

Publication type:

journal article

Interstitial lung disease arising from erlotinib treatment in a Caucasian patient.

Published in:

2015

By:

Bugés, Cristina;
Carcereny, Enric;
Moran, Teresa;
Cardona, Andrés Felipe;
Reguart, Noemi;
Capdevila, Laia;
Cros, Sara;
Rosell, Rafael

Publication type:

journal article

Lung adenocarcinoma harboring concomitant EGFR mutation and EML4-ALK fusion that benefits from three kinds of tyrosine kinase inhibitors: a case report and literature review.

Published in:

2015

By:

Zhao, Ning;
Zheng, Shu-Yi;
Yang, Jin-Ji;
Zhang, Xu-Chao;
Xie, Zhi;
Xie, Bin;
Su, Jian;
Chen, Zhi-Hong;
Chen, Shi-Liang;
Zhang, Na;
Lou, Na-Na;
Dong, Song;
Wu, Yi-Long

Publication type:

journal article

Use of Simultaneous Radiation Boost Achieves High Control Rates in Patients With Non-Small-Cell Lung Cancer Who Are Not Candidates for Surgery or Conventional Chemoradiation.

Published in:

Clinical Lung Cancer, 2015, v. 16, n. 2, p. 156, doi. 10.1016/j.cllc.2014.10.005

By:

Swanick, Cameron W.;
Lin, Steven H.;
Sutton, Jordan;
Naik, Nilan S.;
Allen, Pamela K.;
Levy, Lawrence B.;
Zhongxing Liao;
Welsh, James W.;
Komaki, Ritsuko;
Chang, Joe Y.;
Gomez, Daniel R.

Publication type:

Article

Lung Cancer Hormesis in High Impact States Where Nuclear Testing Occurred.

Published in:

Clinical Lung Cancer, 2015, v. 16, n. 2, p. 152, doi. 10.1016/j.cllc.2014.09.010

By:

Lehrer, Steven;
Rosenzweig, Kenneth E.

Publication type:

Article

Impact of Smoking Status on EGFR-TKI Efficacy for Advanced Non-Small-Cell Lung Cancer in EGFR Mutants: A Meta-analysis.

Published in:

Clinical Lung Cancer, 2015, v. 16, n. 2, p. 144, doi. 10.1016/j.cllc.2014.09.008

By:

Yaxiong Zhang;
Shiyang Kang;
Wenfeng Fang;
Shaodong Hong;
Wenhua Liang;
Yue Yan;
Tao Qin;
Yanna Tang;
Jin Sheng;
Li Zhang

Publication type:

Article

Comparative Effectiveness of First-Line Platinum-Based Chemotherapy Regimens for Advanced Lung Squamous Cell Carcinoma.

Published in:

Clinical Lung Cancer, 2015, v. 16, n. 2, p. 137, doi. 10.1016/j.cllc.2014.09.004

By:

Bin-Chi Liao;
Yu-Yun Shao;
Ho-Min Chen;
Wen-Yi Shau;
Zhong-Zhe Lin;
Nienchen Kuo, Raymond;
Chiu-Ling Lai;
Kuo-Hsing Chen;
Ann-Lii Cheng;
Chih-Hsin Yang, James;
Mei-Shu Lai

Publication type:

Article

An Open-Label, Multicenter, Randomized Phase Ib/II Study of Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2015, v. 16, n. 2, p. 92, doi. 10.1016/j.cllc.2014.10.001

By:

Waller, Cornelius F.;
Vynnychenko, Thor;
Bondarenko, Igor;
Shparyk, Yaroslav;
Hodge, Jeffrey P.;
Freeman, Anne;
Huber, Brian;
Lieberman, Ronald;
Shelton, Mark J.;
Dave, Harish

Publication type:

Article

Prospective Assessment of Pemetrexed or Pemetrexed Plus Platinum in Combination With Gefitinib or Erlotinib in Patients With Acquired Resistance to Gefitinib or Erlotinib: A Phase II Exploratory and Preliminary Study.

Published in:

Clinical Lung Cancer, 2015, v. 16, n. 2, p. 121, doi. 10.1016/j.cllc.2014.09.007

By:

Shaomin Yu;
Bin Zhang;
Chengcheng Xiang;
Yongqian Shu;
Hao Wu;
Xiang Huang;
Qianqian Yu;
Yongmei Yin;
Renhua Guo

Publication type:

Article

Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Renal Impairment.

Published in:

Clinical Lung Cancer, 2015, v. 16, n. 2, p. 112, doi. 10.1016/j.cllc.2014.09.003

By:

Langer, Corey J.;
Hirsh, Vera;
Ko, Amy;
Renschler, Markus F.;
Socinski, Mark A.

Publication type:

Article

ROS1 Immunohistochemistry Among Major Genotypes of Non-Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2015, v. 16, n. 2, p. 106, doi. 10.1016/j.cllc.2014.10.003

By:

Boyle, Theresa A.;
Katsuhiro Masago;
Ellison, Kim E.;
Yasushi Yatabe;
Hirsch, Fred R.

Publication type:

Article

Second-Line Oral Chemotherapy (Lomustine, Cyclophosphamide, Etoposide) Versus Intravenous Therapy (Cyclophosphamide, Doxorubicin, and Vincristine) in Patients With Relapsed Small Cell Lung Cancer: A Randomized Phase II Study of GFPC 0501.

Published in:

Clinical Lung Cancer, 2015, v. 16, n. 2, p. 100, doi. 10.1016/j.cllc.2014.10.002

By:

Gervais, Radj;
Le Caer, Hervé;
Monnet, Isabelle;
Falchero, Lionel;
Baize, Nathalie;
Olivero, Gerard;
Thomas, Pascal;
Berard, Henri;
Auliac, Jean Bernard;
Chouaid, Christos

Publication type:

Article

Incidental Receipt of Cardiac Medications and Survival Outcomes Among Patients With Stage III Non-Small-Cell Lung Cancer After Definitive Radiotherapy.

Published in:

Clinical Lung Cancer, 2015, v. 16, n. 2, p. 128, doi. 10.1016/j.cllc.2014.09.006

By:

Hongmei Wang;
Zhongxing Liao;
Yan Zhuan;
Ying Liu;
Levy, Lawrence B.;
Ting Xu;
Yusuf, Syed Wamique;
Gomez, Daniel R.

Publication type:

Article

Ceritinib (LDK378): A Potent Alternative to Crizotinib for ALK-Rearranged Non-Small-Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2015, v. 16, n. 2, p. 86, doi. 10.1016/j.cllc.2014.09.011

By:

Sen Li;
Xiaolong Qi;
Yufeng Huang;
Dingfeng Liu;
Fangyu Zhou;
Caicun Zhou

Publication type:

Article

Standard Treatment Option in Stage III Non-Small-Cell Lung Cancer: Case Against Trimodal Therapy and Consolidation Drug Therapy.

Published in:

Clinical Lung Cancer, 2015, v. 16, n. 2, p. 80, doi. 10.1016/j.cllc.2014.08.003

By:

Jeremić, Branislav

Publication type:

Article

Radical-Intent Hypofractionated Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer: A Systematic Review of the Literature.

Published in:

Clinical Lung Cancer, 2015, v. 16, n. 2, p. 71, doi. 10.1016/j.cllc.2014.08.002

By:

Raster, Tyler S.;
Yaremko, Brian;
Palma, David A.;
Rodrigues, George B.

Publication type:

Article